Template:Implantable Cardioverter Defibrillator ACC/AHA/HRS Guidelines

Revision as of 15:59, 26 October 2016 by Dima Nimri (talk | contribs) (Created page with "{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" |- | colspan="1" style="text-align:center; background:DarkGray" | 200...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


2008 ACC/AHA/HRS Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Implantable Cardioverter-Defibrillators

Implantable Cardioverter-Defibrillators in Pediatric Patients and Patients With Congenital Heart Disease


HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials

ICD IMPLANTATION IN THE CONTEXT OF AN ABNORMAL TROPONIN THAT IS NOT DUE TO A MYOCARDIAL INFARCTION

[[Implantable Cardioverter Defibrillators #ICD IMPLANTATION WITHIN 40 DAYS OF A MYOCARDIAL INFARCTION]|ICD IMPLANTATION WITHIN 40 DAYS OF A MYOCARDIAL INFARCTION]]

ICD IMPLANTATION WITHIN 90 DAYS OF REVASCULARIZATION

ICD IMPLANTATION <9 MONTHS FROM THE INITIAL DIAGNOSIS OF NONISCHEMIC CARDIOMYOPATHY